Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergmans, D. C J J
Right arrow Articles by Stobberingh, E. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergmans, D. C J J
Right arrow Articles by Stobberingh, E. E
Thorax 1998;53:1053-1058 ( December )

Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit

Dennis C J J Bergmans,a Marc J M Bonten,b Frank H van Tiel,c Carlo A Gaillard,d Siebe van der Geest,a Rob M Wilting,a Peter W de Leeuw,a Ellen E Stobberinghc

a Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands, b Department of Internal Medicine, University Hospital Utrecht, Utrecht, The Netherlands, c Department of Medical Microbiology, University Hospital Maastricht, Maastricht, The Netherlands, d Department of Internal Medicine, Eemland Hospital, Amersfoort, The Netherlands

Correspondence to: Dr D C J J Bergmans, Department of Internal Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.

Received 9 February 1998; Returned to authors 18 May 1998; Revised version received 17 June 1998; Accepted for publication 6 July 1998

BACKGROUND---Ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa is usually preceded by colonisation of the respiratory tract. During outbreaks, colonisation with P aeruginosa is mainly derived from exogenous sources. The relative importance of different pathways of colonisation of P aeruginosa has rarely been determined in non-epidemic settings.
METHODS---In order to determine the importance of exogenous colonisation, all isolates of P aeruginosa obtained by surveillance and clinical cultures from two identical intensive care units (ICUs) were genotyped with pulsed field gel electrophoresis.
RESULTS---A total of 100 patients were studied, 44 in ICU 1 and 56 in ICU 2. Twenty three patients were colonised with P aeruginosa, seven at the start of the study or on admission and 16 of the remaining 93 patients became colonised during the study. Eight patients developed VAP due to P aeruginosa. The incidence of respiratory tract colonisation and VAP with P aeruginosa in our ICU was similar to that before and after the study period, and therefore represents an endemic situation. Genotyping of 118 isolates yielded 11 strain types: eight in one patient each, two in three patients each, and one type in eight patients. Based on chronological evaluation and genotypical identity of isolates, eight cases of cross-colonisation were identified. Eight (50%) of 16 episodes of acquired colonisation and two (25%) of eight cases of VAP due to P aeruginosa seemed to be the result of cross-colonisation.
CONCLUSIONS---Even in non-epidemic settings cross-colonisation seems to play an important part in the epidemiology of colonisation and infection with P aeruginosa.

Keywords: colonisation; Pseudomonas aeruginosa; ventilator-associated pneumonia


© 1998 by Thorax



This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
C. Pena, A. Guzman, C. Suarez, M. A. Dominguez, F. Tubau, M. Pujol, F. Gudiol, and J. Ariza
Effects of Carbapenem Exposure on the Risk for Digestive Tract Carriage of Intensive Care Unit-Endemic Carbapenem-Resistant Pseudomonas aeruginosa Strains in Critically Ill Patients
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1967 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
V. Aloush, S. Navon-Venezia, Y. Seigman-Igra, S. Cabili, and Y. Carmeli
Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J.-P. Pirnay, D. De Vos, C. Cochez, F. Bilocq, J. Pirson, M. Struelens, L. Duinslaeger, P. Cornelis, M. Zizi, and A. Vanderkelen
Molecular Epidemiology of Pseudomonas aeruginosa Colonization in a Burn Unit: Persistence of a Multidrug-Resistant Clone and a Silver Sulfadiazine-Resistant Clone
J. Clin. Microbiol., March 1, 2003; 41(3): 1192 - 1202.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. P. Lynch III
Hospital-Acquired Pneumonia : Risk Factors, Microbiology, and Treatment
Chest, February 1, 2001; 119(2_suppl): 373S - 384S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & British Thoracic Society